Education
About Us
Working with TipRanks
Follow Us
Roche Holding AG (RHHVF)
OTHER OTC:RHHVF
RHHVF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$233.12 - $354.19
Previous CloseN/A
Volume301.00
Average Volume (3M)3.30K
Market Cap
$279.31B
Enterprise Value$228.34B
Total Cash (Recent Filing)CHF5.38B
Total Debt (Recent Filing)CHF30.78B
Price to Earnings (P/E)29.2
Beta0.17
Next Earnings
Jul 24, 2025EPS Estimate
12.05Last Dividend Ex-Date
Mar 27, 2025Dividend Yield3.14%
Share Statistics
EPS (TTM)11.74
Shares Outstanding702,562,700
10 Day Avg. Volume2,605
30 Day Avg. Volume3,301
Financial Highlights & Ratios
PEG Ratio18.03
Price to Book (P/B)N/A
Price to Sales (P/S)3.40
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$330.88Price Target Upside-2.68% Downside
Rating ConsensusHold
Number of Analyst Covering10
---
Bulls Say, Bears Say
Bulls Say
Clinical ReadoutsRoche will deliver a substantial number of clinical readouts, which can decide a turnaround to the story.
Financial PerformanceEPS downgrade cycle has troughed, with FY25E EPS now ahead of consensus, driven by better performance in Xolair, Vabysmo, and pharma margin progression.
Bears Say
Competition And SafetyData have not shown a clear benefit vs competition and safety does not seem to provide any advantage.
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
10.03% Mutual Funds
0.04% Other Institutional Investors
79.67% Public Companies and
Individual Investors
RHHVF FAQ
What was Roche Holding AG’s price range in the past 12 months?
Roche Holding AG lowest stock price was $233.12 and its highest was $354.19 in the past 12 months.
What is Roche Holding AG’s market cap?
Roche Holding AG’s market cap is $279.31B.
When is Roche Holding AG’s upcoming earnings report date?
Roche Holding AG’s upcoming earnings report date is Jul 24, 2025 which is in 119 days.
How were Roche Holding AG’s earnings last quarter?
Roche Holding AG released its earnings results on Jan 30, 2025. The company reported $9.705 earnings per share for the quarter, beating the consensus estimate of $9.195 by $0.51.
Is Roche Holding AG overvalued?
According to Wall Street analysts Roche Holding AG’s price is currently Overvalued.
Does Roche Holding AG pay dividends?
Roche Holding AG pays a Annually dividend of $10.983 which represents an annual dividend yield of 3.14%. See more information on Roche Holding AG dividends here
What is Roche Holding AG’s EPS estimate?
Roche Holding AG’s EPS estimate is 12.05.
How many shares outstanding does Roche Holding AG have?
Roche Holding AG has 702,562,700 shares outstanding.
What happened to Roche Holding AG’s price movement after its last earnings report?
Roche Holding AG reported an EPS of $9.705 in its last earnings report, beating expectations of $9.195. Following the earnings report the stock price went up 1.384%.
Which hedge fund is a major shareholder of Roche Holding AG?
Currently, no hedge funds are holding shares in RHHVF
---
Company Description
Roche Holding AG
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, and internationally. The company offers pharmaceutical products in the therapeutic areas of oncology, neuroscience, infectious diseases, immunology, hemophilia, ophthalmology, dermatology, respiratory, anemia, inflammatory and autoimmune, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, cardiovascular, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD). Roche Holding AG was founded in 1896 and is headquartered in Basel, Switzerland.
---
RHHVF Company Deck
---
RHHVF Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Roche demonstrated strong financial performance in 2024 with significant growth in sales, operating profit, and cash flow. The pharmaceutical and diagnostics divisions both showed robust growth, supported by strategic acquisitions and new product launches. However, challenges such as the decline in COVID-19 sales, impairments affecting net income, and market challenges in China were notable concerns. Overall, the highlights substantially outweigh the lowlights.Read More>---
RHHVF Stock 12 Month Forecast
Average Price Target
$330.88
▼(-2.68% Downside)
Technical Analysis
Best Analysts Covering RHHVF
1 Year
1 Year Success Rate
27/46 ratings generated profit
1 Year Average Return
+2.85%
reiterated a sell rating 2 days ago
Copying Richard Vosser's trades and holding each position for 1 Year would result in 58.70% of your transactions generating a profit, with an average return of +2.85% per trade.
---